Due to the spiked COVID-19 cases worldwide, the qPCR and dPCR techniques is expected to experience good growth in the near future; according to a research conducted by Kenneth Research

 Cancer was the leading reason of death in 2018, according to the World Health Organization (WHO). And the data is ever-increasing. The surge in active cases of cancer and HIV worldwide, the real-time PCR (qPCR) and digital PCR (dPCR) market is expected to grow at an annual growth rate of almost 9% in the next 10 to 15 years.


In 2021, the global market for real-time PCR (qPCR) and digital PCR (dPCR) is estimated to be approximately US$3 billion. It is expected to grow at a compound annual growth rate of 9% during the forecast period from 2022-2030. The epidemiology of target diseases and rapid technological progress, such as the development of high-throughput systems, qPCR systems, and dPCR systems, can become an important driving force for growth. According to the World Health Organization (WHO), cancer was the leading cause of death in 2018, and 9.6 million people worldwide died of cancer. The World Health Organization (WHO) estimates that 36.9 million people were infected with HIV in 2017. It is related to infectious diseases. The main cause of death worldwide in 2016.


The high prevalence of these diseases should predict the future market. In addition, the continuous efforts of PCR manufacturers to develop new systems and kits for molecular detection will drive the growth of the qPCR and dPCR markets. For example, in January 2019, QIAGEN NV announced plans to develop the next-generation dPCR system, which will be launched on the market in 2020. These new systems are expected to provide highly automated workflows and faster response times than digital PCR. operating system. This may be an important competitive advantage for the company. In addition, the wide application of qPCR and dPCR technologies is expected to further improve the reliability of the target. These techniques are widely used in basic and clinical research. They are widely used in the fields of human genetic testing, forensic medicine, pathogen diagnosis and infectious disease detection.

Major market players:

Bio-rad labs, Thermo Fisher Scientific Society, Qiagen NV, Abbott Laboratories, Inc. Agilent Technologies, Inc. Biomarix SA, Fluidigm Company. and f. Hoffman La method.

According to technology, the real-time PCR (qPCR) and digital PCR (dPCR) markets are divided into quantitative and digital. The market share of PCR easily reached the first place in 2018. Growing demands in areas such as gene mutation analysis, gene expression, and genotyping are driving interest in the development of long-term care operating system platforms (POC). By 2020, it will have the largest market share. With the introduction of new PCR test kits, this market segment is expected to grow significantly compared to other regions. In October 2017, AOAC International, an independent standard-setting body of the Bio-Rad Institute, approved iQ-Check (Real-time PCR Kit) as the official analytical method for detecting Salmonella strains in raw meat.

The approval process paved the way for the group’s use in a wide range of industrial applications in the meat industry. The research plan played an important role in 2018. qPCR and dPCR systems are widely used in stem cell research, genetic disease research, and oncology research applications. The heavy use of these systems is due to features such as improved data security and faster response time. Due to the increasing acceptance of automated procedures, the clinical application industry will achieve the highest annual growth rate of 8.7% during the forecast period.

Main market regions:
The study on real-time PCR (qPCR) and digital PCR (dPCR) market was global in nature and conducted in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa). In addition, areas like Market size, Y-O-Y growth & Opportunity Analysis, market players competitive study, investment opportunities, demand for future outlook etc. have been covered and displayed in the Global real-time PCR (qPCR) and digital PCR (dPCR) market research report to ensure it dives deep to achieve strategic competitive intelligence in the segment. 

Comments

Popular posts from this blog

Regulatory Technology (RegTech) Market 2021 Report On Research Report 2021, Size, CAGR Value, Growth Rate, Latest Trends, Business Investment Plans, SWOT Analysis, Forecast to 2030

Bio based PET Market 2021 Share and Size, Expected CAGR, Top Manufacturers and Consumer Analysis across the Region and Globe, Opportunities and Growth till 2025

Global Wearable Medical Devices Market Report – Future Demand and Market Prospect Forecast (2022-2031)